Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Buy
601,844
+169,133
+39% +$731K ﹤0.01% 5353
2026
Q1
$1.67M Sell
432,711
-81,469
-16% -$334K ﹤0.01% 6582
2025
Q4
$2.15M Buy
514,180
+438,905
+583% +$1.7M ﹤0.01% 5508
2025
Q3
$248K Sell
75,275
-1,064,427
-93% -$3.01M ﹤0.01% 10542
2025
Q2
$1.62M Buy
1,139,702
+975,244
+593% +$1.39M ﹤0.01% 6251
2025
Q1
$245K Sell
164,458
-540,435
-77% -$851K ﹤0.01% 10512
2024
Q4
$789K Buy
704,893
+655,113
+1,316% +$559K ﹤0.01% 7547
2024
Q3
$47.1K Sell
49,780
-91,863
-65% -$116K ﹤0.01% 11404
2024
Q2
$224K Buy
+141,643
New +$206K ﹤0.01% 10103
2024
Q1
Sell
-90,561
Closed -$130K 13064
2023
Q4
$121K Sell
90,561
-61,452
-40% -$72.2K ﹤0.01% 11168
2023
Q3
$216K Buy
152,013
+78,360
+106% +$111K ﹤0.01% 10067
2023
Q2
$84.7K Sell
73,653
-59,186
-45% -$69.9K ﹤0.01% 11068
2023
Q1
$141K Buy
132,839
+20,089
+18% +$29K ﹤0.01% 10978
2022
Q4
$171K Buy
112,750
+24,902
+28% +$42.8K ﹤0.01% 10337
2022
Q3
$186K Sell
87,848
-136,403
-61% -$288K ﹤0.01% 10948
2022
Q2
$300K Sell
224,251
-53,970
-19% -$80.1K ﹤0.01% 9565
2022
Q1
$587K Sell
278,221
-435,308
-61% -$1.06M ﹤0.01% 8564
2021
Q4
$2.65M Buy
713,529
+112,381
+19% +$484K ﹤0.01% 4870
2021
Q3
$3M Buy
601,148
+104,082
+21% +$599K ﹤0.01% 4952
2021
Q2
$3.24M Buy
497,066
+702
+0.1% +$4.91K ﹤0.01% 4849
2021
Q1
$3.42M Sell
496,364
-403,998
-45% -$3.42M ﹤0.01% 4675
2020
Q4
$9.18M Buy
900,362
+357,201
+66% +$2.32M ﹤0.01% 2598
2020
Q3
$1.9M Sell
543,161
-63,541
-10% -$302K ﹤0.01% 4724
2020
Q2
$3.03M Buy
606,702
+188,941
+45% +$643K ﹤0.01% 3792
2020
Q1
$1.42M Sell
417,761
-217,260
-34% -$938K ﹤0.01% 4603
2019
Q4
$3.48M Sell
635,021
-24,670
-4% -$139K ﹤0.01% 3473
2019
Q3
$3.77M Buy
659,691
+136,069
+26% +$925K ﹤0.01% 3134
2019
Q2
$4.01M Buy
523,622
+436,082
+498% +$2.35M ﹤0.01% 3022
2019
Q1
$460K Sell
87,540
-160,459
-65% -$1.11M ﹤0.01% 6436
2018
Q4
$1.62M Buy
+247,999
New +$2.78M ﹤0.01% 3839
2018
Q3
Sell
-124,121
Closed -$1.85M 9984
2018
Q2
$1.73M Sell
124,121
-442,612
-78% -$7.48M ﹤0.01% 4262
2018
Q1
$8.69M Buy
566,733
+4,073
+0.7% +$58.2K ﹤0.01% 1921
2017
Q4
$6.48M Buy
562,660
+450,497
+402% +$6.71M ﹤0.01% 2251
2017
Q3
$2.13M Sell
112,163
-154,143
-58% -$3.17M ﹤0.01% 3787
2017
Q2
$6.42M Buy
266,306
+59,640
+29% +$1.31M ﹤0.01% 2116
2017
Q1
$4.1M Sell
206,666
-10,529
-5% -$235K ﹤0.01% 2583
2016
Q4
$5.23M Sell
217,195
-66,524
-23% -$1.85M ﹤0.01% 2360
2016
Q3
$7.88M Buy
283,719
+86,794
+44% +$2.3M ﹤0.01% 1741
2016
Q2
$4.8M Sell
196,925
-139,396
-41% -$3.95M ﹤0.01% 2259
2016
Q1
$11.3M Sell
336,321
-274,100
-45% -$8.63M 0.01% 1441
2015
Q4
$18.2M Buy
610,421
+203,189
+50% +$6.85M 0.01% 1211
2015
Q3
$12.8M Buy
407,232
+82,544
+25% +$4.03M 0.01% 1593
2015
Q2
$15.7M Sell
324,688
-21,278
-6% -$897K 0.01% 1537
2015
Q1
$15M Buy
345,966
+112,685
+48% +$4.05M 0.01% 1491
2014
Q4
$6.14M Buy
233,281
+107,845
+86% +$2.36M ﹤0.01% 2606
2014
Q3
$2.23M Buy
125,436
+73,038
+139% +$1.49M ﹤0.01% 4411
2014
Q2
$1.26M Sell
52,398
-75,070
-59% -$1.52M ﹤0.01% 5564
2014
Q1
$3.2M Buy
127,468
+57,054
+81% +$1.58M ﹤0.01% 3536
2013
Q4
$1.6M Sell
70,414
-61,122
-46% -$1.24M ﹤0.01% 4668
2013
Q3
$2.98M Buy
+131,536
New +$3.04M ﹤0.01% 3496

Other funds holding PGEN

Jeff Yass's PGEN Position: Q2 2026 in Review

Jeff Yass increased its Precigen (PGEN) stake by 39% in Q2 2026, buying an estimated $731K and bringing the position to 601,844 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #5353.

Jeff Yass first reported a position in PGEN in Q3 2013 and has held it in 50 quarters since. The position peaked at $18.2M in Q4 2015. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Jeff Yass held 601,844 shares of Precigen worth $3.43M as of Q2 2026.
  • Jeff Yass bought 169,133 Precigen shares in Q2 2026, an estimated $731K.
  • Precigen made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5353 holding.
  • Jeff Yass first reported a position in Precigen in Q3 2013 and has held it in 50 quarters since.
  • Jeff Yass's Precigen position peaked at $18.2M in Q4 2015.
  • 209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.